News & Articles

The device promises rapid discrimination between benign and malignant epithelial ovarian cysts within 15 minutes

The respiratory/sore throat (R/ST) panel receives Dual 510(k) clearance and CLIA-waiver approval

New device rapidly isolates blood plasma for diagnostics and precision medicine

Cologuard Plus was evaluated against an independent fecal immunochemical test, which it significantly outperformed

The Tumor Tissue Modified Viral (TTMV)-HPV DNA blood test aids in the detection of HPV-driven cancer

Study shows blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90%

Collaboration aims to expand optimal genetic testing for individual diseases

Portuguese researchers, INESC TEC, and the IMP Diagnostics Molecular & Anatomic Pathology laboratory, focus on improving the prototype that uses AI as a complementary tool when diagnosing colon and rectal biopsies

A new test diagnoses patients with melioidosis within hours, rather than days, meaning they can receive the correct antibiotics faster

The partnership focuses on development, manufacturing and clinical adoption of neurodegenerative disease assays

New Aptiva® APS IgG and APS IgM reagents enable early diagnosis of Antiphospholipid Syndrome in hard-to-diagnose autoimmune disease

Through a combination of advanced imaging and novel artificial intelligence, latest diagnostic system for cervical cancer screening can help more accurately detect disease, improve workflow and enhance patient care

The Selux PBC Separator, part of the Next Generation Phenotyping (NGP) System, makes this the only FDA cleared, single-platform technology capable of delivering rapid AST results for both positive blood culture and isolated colonies

David Wells, CEO of the IBMS, discusses the Institute’s plans to ensure the future of biomedical science careers

Sysmex Corporation announces that it has entered a strategic alliance agreement with CellaVision

The beta thalassemia test could help couples make informed reproductive choices, ensure appropriate maternal care, and facilitate diagnosis in infants

New study finds that persistent COVID-19 infections are surprisingly common, with around one to three in every 100 infections lasting a month or longer

Leveraging Quanterix’s Simoa platform, researchers lay the groundwork for pre-symptomatic Alzheimers diagnosis, guided treatment, and accelerated clinical drug trials

Examine the benefits and logistics of transitioning your program from traditional site-based blood collection to remote sampling

AI-based algorithm aims to enable cytotechnologists and pathologists to efficiently identify evidence of cervical cancer and precancerous lesions, using AI-based digital cervical system for pap testing.

Dr. Julienne Carstens highlights the critical role of spatial biology in understanding the metastatic progression of PDAC and advancing personalized immunotherapy

In this guest editorial, discover how Capitainer® DBS cards with qDBS technology enable easy self-sampling with precision and accuracy

HORIBA Evolutive Laboratory Organisation (HELO) 2.0 embeds advanced hematology technologies to offer flexible, high-throughput, high-quality analytical performance

The new assay allows for the quantitative measurement of Tau phosphorylated